ArticleScientific reports2026
COVID-19 pandemic and vaccine hesitancy in a Brazilian state capital.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic was disclosed to have both positive and negative impacts on vaccine acceptance. To further comprehend its influences on the population’s perceptions about vaccination, we conducted a cross-sectional study that aimed to evaluate the trends and determinants of vaccine hesitancy before and after the onset of the COVID-19 pandemic, in Campo Grande, a state capital in Brazil. Data was collected through household interviews conducted between 2022 and 2023, using questions addressing both the pre- and post-pandemic periods. Information on socioeconomic and demographic characteristics, COVID-19 vaccine hesitancy, and the number of COVID-19 vaccine doses received was collected. Vaccine hesitancy over time was assessed using the World Health Organization 10-item Vaccine Hesitancy Scale (VHS), applied retrospectively to the periods before and after the beginning of the pandemic. Positive items were reverse-scored so that higher score indicated greater vaccine hesitancy. Some items of the VHS were aligned in two factors (lack of trust and risk perception) and two bivariable and two linear regression models were performed to describe the association between the variables and those factors. We observed an increase in both factors and in the overall VHS score after the onset of the pandemic. Lower trust was associated with older age, whereas lower COVID-19 vaccine hesitancy was associated with a higher number of COVID-19 vaccine doses received. Increased risk perception was associated with higher COVID-19 vaccine hesitancy. These findings suggest that the COVID-19 pandemic contributed to an overall rise in vaccine hesitancy in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.